201 related articles for article (PubMed ID: 6381284)
1. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Epstein JI; Eggleston JC
Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
[TBL] [Abstract][Full Text] [Related]
2. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
3. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
Keillor JS; Aterman K
J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
[TBL] [Abstract][Full Text] [Related]
4. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
5. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
[TBL] [Abstract][Full Text] [Related]
7. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Shah NT; Tuttle SE; Strobel SL; Gandhi L
J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Epstein JI; Woodruff JM
Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Steffens J; Friedmann W; Lobeck H
Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
[TBL] [Abstract][Full Text] [Related]
11. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
Warhol MJ; Longtine JA
J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
Fan K
J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Sauvageot J; Epstein JI
Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
[TBL] [Abstract][Full Text] [Related]
14. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
15. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Svanholm H
Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
[TBL] [Abstract][Full Text] [Related]
17. [Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma].
Yamaguchi K; Sumiya H; Fuse H; Ito H; Shimazaki J; Matsuzaki O
Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):786-90. PubMed ID: 2427766
[No Abstract] [Full Text] [Related]
18. Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
Ro JY; el-Naggar A; Ayala AG; Mody DR; Ordóñez NG
Am J Surg Pathol; 1988 Jun; 12(6):453-60. PubMed ID: 2454036
[TBL] [Abstract][Full Text] [Related]
19. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
[TBL] [Abstract][Full Text] [Related]
20. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]